Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2015.07.012DOI Listing

Publication Analysis

Top Keywords

atopic keratoconjunctivitis
4
keratoconjunctivitis children
4
children clinical
4
clinical features
4
features diagnosis
4
atopic
1
children
1
clinical
1
features
1
diagnosis
1

Similar Publications

Eczema Herpeticum: A Fatal Rash That Mimics Many.

S D Med

September 2024

Avera Medical Group Infectious Disease Specialists, Sioux Falls, South Dakota.

Eczema herpeticum (EH) is a potentially life-threatening condition, especially in the pediatric population, that occurs among patients with atopic dermatitis (AD). AD is a chronic inflammatory skin disorder with a complex pathophysiology that predisposes patients to EH. Herpes simplex virus (HSV) 1 is implicated in 90 % of EH cases and often initially presents with gingivostomatitis.

View Article and Find Full Text PDF

In vivo confocal microscopy (IVCM) is a non-invasive imaging technique used to visualize the layers of the cornea and conjunctiva in real time. In patients with atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC), this technology can be useful in diagnosing and monitoring the disease, as well as evaluating the efficacy of treatments. IVCM can reveal subclinical abnormalities in the corneal and conjunctival epithelium such as inflammatory cell infiltrates and tissue damage, which can provide insight into the pathogenesis of AKC.

View Article and Find Full Text PDF

Allergic conjunctivitis (AC) is characterized by inflammatory responses in the conjunctiva and is often complicated by atopic dermatitis and mechanical irritation. Vernal keratoconjunctivitis (VKC), a severe subtype of AC, presents unique challenges in its diagnosis and management, particularly in pediatric patients. This case report describes an eight-year-old girl with VKC who exhibited poor adherence to a prescribed regimen of 0.

View Article and Find Full Text PDF

[Efficacy of biologics for severe asthma on allergic comorbidities].

Rev Mal Respir

November 2024

Service de pneumologie et centre de référence des maladies pulmonaires rares, AP-HP Nord, hôpital Bichat, 75018 Paris, France; Inserm UMR1152, université Paris Cité, Paris, France.

Article Synopsis
  • Some treatments called biologics can help people with severe asthma and other allergic diseases like skin issues and food allergies.
  • Dupilumab has been shown to work well for skin problems and has been approved, while Omalizumab helps with allergies but isn't approved for that use yet.
  • There are promising ideas about combining biologic therapy with other treatments for allergies, but more research is needed to confirm if they really work.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!